Proyectos de ley › 90.ª Asamblea General
Relating to the provision of covered vaccine information, relating to the federal vaccine adverse event reporting system and the national vaccine injury compensation program
Temas:Health care
Dónde está ahora
- Hecho: Presentado15 de febrero de 2024
- Se detuvo: SubcomitéMurió al terminar la Asamblea General
- Sigue: Comité de la Cámara
- Sigue: Lo aprueba la Cámara
- Sigue: Comité del Senado
- Sigue: Lo aprueba el Senado
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Murió al terminar la sesión La sesión de 2024 terminó el 19 de abril de 2024, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?
Qué contiene
Resumen con IA Healthcare providers must verbally tell patients about federal programs for reporting vaccine side effects and getting compensation for injuries before giving a vaccine. Additionally, any advertisements for vaccines in Iowa must include a statement explaining that vaccine manufacturers have limited legal liability for injuries. (Todavía no está traducido al español.)1
Lea la explicación oficial (en inglés)
This bill relates to the information that must be provided regarding the limitation of the liability of a manufacturer of a covered vaccine under federal law prior to the administration of a covered vaccine and in any advertisement of the covered vaccine in the state. The bill requires a health care provider who is licensed or authorized to administer covered vaccines, to verbally provide to the patient prior to the administration of a covered vaccine, information regarding the federal vaccine adverse event reporting system and the national vaccine injury compensation program, including information regarding the limitation of the covered vaccine manufacturer’s liability for a vaccine injury related to the vaccine. The bill also requires that any advertisement distributed in the state for a covered vaccine via radio, newspaper, television, internet, or other medium, shall include a statement regarding the limitation of the liability of the manufacturer of the covered vaccine for any vaccine injury related to the covered vaccine under the national vaccine injury compensation program.